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Phage applicationsThe use of phages to control pathogenic bacteria has been investigated since theywereﬁrst discovered in the be-
ginning of the 1900s. Over the last century we have slowly gained an in-depth understanding of phage biology
including which phage properties are desirable when considering phage as biocontrol agents and which phage
characteristics to potentially avoid. Campylobacter infections are amongst the most frequently encountered
foodborne bacterial infections around the world. Handling and consumption of raw or undercooked poultry
products have been determined to be the main route of transmission. The ability to use phages to target these
bacteria has been studied for more than a decade and although we have made progress towards deciphering
how best to use phages to control Campylobacter associated with poultry production, there is still much work
to be done. This review outlines methods to improve the isolation of these elusive phages, as well as methods
to identify desirable characteristics needed for a successful outcome. It also highlights the body of research un-
dertaken so far andwhat criteria to consider when doing in-vivo studies, especially because some in-vitro studies
have not been found to translate into to phage efﬁcacy in-vivo.
© 2013 The Authors. Published by Elsevier B.V. Open access under CC BY-NC-ND license.1. Introduction
Sebald and Véron ﬁrst proposed the Campylobacter genus in
1963 and the number of members in the genus is constantly
increasing due to improved isolation and detection methodologies
(Butzler, 2004). There are currently 25 species in the Campylobac-
ter genus (Man, 2011). They are typically microaerobic spiral-
shaped Gram-negative cells, but have been found to also grow
aerobically and anaerobically. They are thermophilic and have an
optimum growth temperature of 42 °C but can grow at 30 °C.
Their reservoirs are warm-blooded animals such as cattle, sheep,
pigs, poultry, wildlife and domestic pets. Animal carriers are generally
asymptomatic, but the species C. fetus can cause diarrhea and aseptic
abortions in large animals (Moore et al., 2005). Most human
campylobacteriosis are due to C. jejuni (90%) with a few due to C. coli
(10%) (Wilson et al., 2008). Other species such as C. upsaliensis, C. lari,
and C. fetus, have also been associated with human diarrhea, particular-
ly in the developing world (Coker et al., 2002; Man, 2011)., School ofMedicine, University
arrillo).
.V. Open access under CC BY-NC-ND liIn the United States, there are 9.4 million reported cases of
foodborne illnesses each year. The third most prevalent bacterial
pathogen causing 9% of those cases are attributed to Campylobacter
species (Scallan et al., 2011) with an estimated annual cost of illness
to be $1.7 billion (Hoffmann et al., 2012). However, in Europe
campylobacteriosis is the most common foodborne bacterial illness
and estimates of the true incidence rate for Campylobacter-associated
infections is 9.2 million, with a total annual cost of €2.4 billion (EFSA,
2011). Underreporting from such infections could be due to its
self-limiting nature, which presents as an acute gastrointestinal illness
resulting in diarrhea, fever and abdominal crampswith ameanduration
of six days (Butzler, 2004; Man, 2011). Campylobacteriosis is the most
frequently reported zoonotic disease in the EU, with poultry meat
being the major source for human cases (EFSA, 2011). In the U.S.
Campylobacter species are found to cause the most illnesses attributed
to animal contact, although they are second to nontyphoidal Salmonella
as pathogens causing hospitalization or death (Hale et al., 2012).
Up to 30% of human cases are due to handling, preparation and
consumption of raw or undercooked poultry, although the routes of
transmission from chickens to humans are not well understood
(EFSA, 2011). A linear relationship has been found between the prev-
alence of Campylobacter in broiler ﬂocks and the risk to public health
through quantitative risk assessment studies of interventions in the
primary production in four European countries (Nauta et al., 2009).
A 90% reduction in the risk to public health could be obtained by
reducing the number of Campylobacter in broiler intestines by 3
Logs, and even a 1 Log reduction on the carcasses would reduce the
risk to between 50 and 90% (EFSA, 2011).cense.
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Preventative measures during primary production to prevent
Campylobacter from being transmitted to a ﬂock requires adequate
biosecurity implementations such as use of modern housing that is
well maintained and with limited access. Boot dips, and ﬂy screens
have both been found to reduce the risk of ﬂock infection. However,
in order to maximize the reduction of Campylobacter-positive ﬂocks
at the farm level, complimentary non-biosecurity measures, such as
thoroughness of cleaning and disinfecting the poultry house between
ﬂocks, are also necessary (Newell et al., 2011). Reducing ﬂock suscep-
tibility to infection by using appropriately treated water for drinking,
reducing slaughter age and discontinuing thinning are important
strategies at preventing ﬂock colonization by Campylobacter, or at
least delaying its onset until close to slaughter (Newell et al., 2011).
At the processing plant, the various stages of processing chicken car-
casses (i.e. chilling, washing, defeathering, scalding and evisceration)
have shown a limited effect at reducing the presence of Campylobacter
(Guerin et al., 2010). Post-slaughter — only irradiation or cooking on
an industrial scale can reduce the risk by 100%. Freezing the carcasses
for 2–3 weeks can help reduce the risk by N90%, whereas freezing for
2–3 days will reduce the risk between 50 and 90%, similar to carcass
decontamination using hot water, lactic acid, acidiﬁed sodium chlorite
or trisodium phosphate (Whyte et al., 2003; Riedel et al., 2009;
Sampers et al., 2010; EFSA, 2011; Meredith et al., 2013).
One particular strategy that has been investigated for its potential
application to reduce the load of Campylobacter in chickens, from
the primary intervention stage through to the packaging stages of
processed carcasses, is the use of bacteriophages (Atterbury et al.,
2003b; Goode et al., 2003; Loc Carrillo et al., 2005; Wagenaar et al.,
2005). Bacteriophages (also known as phages) are bacterial viruses
that can only lyse targeted bacterial cells.
The speciﬁcity of phages to target bacteria is dependent on cell
surface receptors such as outer membrane and lipopolysaccharide
proteins as well as ﬂagella components (Lindberg, 1973; Scott et al.,
2007a; Holst Sorensen et al., 2011). Once the phage is irreversibly
attached, its DNA is ejected into the cell and takes over the host's DNA
replication, transcription and translation processes. Phage components
are manufactured by the bacterium and then assembled to make
progeny phage, which exit the cell with the aid of lysins. These ‘new’
phages are then capable of infecting other target cells nearby.
3. Isolation and characterization of Campylobacter phages
The ideal phages for use as therapeutic or biocontrol agents on path-
ogenic bacteria such as Campylobacter must meet a few criteria before
being considered as suitable candidates. They must be obligately lytic
and therefore only capable of infecting bacterial cells and producing
progeny phage without the capacity to integrate into the bacterial ge-
nome or transduce bacterial genes from one cell to another (Canchaya
et al., 2003). These therapeutic phages should also possess physical
characteristics that will facilitate their survival in the environments
they will be applied to, i.e. stable at high temperature (such as the
body temperature of live chickens, 42 °C), stable at low pH (such as
that found in the chicken gut, pH 2–4) and have well-characterized
lytic activity against target bacteria but not commensals (Loc Carrillo,
2005; Hansen et al., 2007).
3.1. Isolation
The best sources to isolate phage are from environments where
the host is highly prevalent. Campylobacter is ubiquitous in temperate
environments but favors the intestine of all avians, where they colo-
nize the gut as a commensal organism (Newell and Fearnley, 2003).
By isolating the Campylobacter strains from the same location as
their phage, there is a higher probability of having a host susceptibleto the phages sought. Failing the possibility of isolating ‘native’ hosts,
possessing a highly susceptible strain such as C. jejuni NCTC 12662,
which is known to be sensitive to most C. jejuni and C. coli phage
isolates, is an alternative solution (Connerton et al., 2004; Loc Carrillo,
2005; Owens et al., 2012).
Phage isolation begins with the collection and preparation of the
environmental sample. Campylobacter phages have been isolated
from retail poultry, feces and intestines of chickens and ducks, abat-
toir efﬂuents, human feces, pig and poultry manure, as well as sewage
(Grajewski et al., 1985; Salama et al., 1989; Atterbury et al., 2003a;
Connerton et al., 2004; El-Shibiny et al., 2005; Hansen et al., 2007;
Loc Carrillo et al., 2007; Owens et al., 2012). However, to date no
Campylobacter phages have been recovered from cattle, rabbit and
sheep feces, farm pasture soil, or water samples (Grajewski et al.,
1985; Bigwood and Hudson, 2009).
Amodiﬁed procedure by Salama and colleagues is particularly useful
at isolating Campylobacter phages. Phages are eluted from solid matrix
samples (e.g., feces and intestinal content) by suspending the material
(1:10) in a suitable buffered solution such as Salt-Magnesium (SM)
buffer. The suspension is then centrifuged to remove debris and the
supernatant transferred to a new tube and centrifuged at higher speeds
to remove most bacteria. Finally, the resulting supernatant is then
ﬁltered through a 0.2 μm pore-size (low-protein binding) ﬁlter to
remove any remaining bacteria. The use of chloroform is not
recommended due to some phages being sensitive to the chemical.
Vortexing of the samples should also be limited as phages with
long tail ﬁbers may be physically damaged and become uninfective.
The ﬁltrate is then ready to be applied as (10 μL) spots onto lawns, or
(100 μL) mixed with the bacterial culture to make pour plates with
the target Campylobacter strains (Salama et al., 1989). This method
is simple and takes three days to complete.
Preparation of the target bacteria is also an important step
towards isolating Campylobacter phage. Campylobacter cells should
be harvested in brain heart infusion (BHI) broth, supplemented
with 10 mM MgSO4 and 1 mM CaCl2 since the presence of these
cations are necessary for a number of phage types to attach to their
cell surface receptors. The use of selective media such as NZCYM
broth with 1.5% select agar +10 μg/mL vancomycin can be useful
when trying to isolate phages from fecal or other heavily contami-
nated samples. Bacterial lawns using known highly susceptible
Campylobacter strains can increase the likelihood of isolating phages,
as is using strains isolated from the same environmental source.
All lawnplates should be incubated for 24 h at 42 °C undermicroaerobic
conditions. Any plaques seen are then cored-out with the aid of a sterile
1 mL pipette tip and suspended into SM buffer. Single plaques should
be propagated three times to ensure that the phage isolates represent
a single clone.
An enrichment method can be used to amplify very low numbers
of phage present in a sample. For an outline of the method, see
Carvalho et al., 2010a. In brief this method involves using a mixture
of target/indicator Campylobacter strains instead of a single strain. Fil-
tered samples can then be added to the exponentially growing Cam-
pylobacter mixture, allowing any phage present to propagate in any
susceptible host, and making them easier to be detected when spot-
ting onto susceptible bacterial lawns.
When searching for Campylobacter phage, it is important to consider
the predator–prey relationship that ties phage to their host. Phage
replication is dependent on a host density threshold (Payne and
Jansen, 2003) and if the host population is low the probability of isolat-
ing phage is signiﬁcantly reduced. This correlation was seen during a
survey of broiler houses in the UK between January 2001 and June
2002. No phages were isolated when Campylobacter was not detected
in the chicken excreta and cloacal swab samples collected (Loc
Carrillo, 2005). Of the 798 samples from 12 different farms, collected
between one to four times per farm over the 18-month period, 71%
were positive for Campylobacter and only 45% contained detectable
Fig. 1. TEM of Campylobacter phage attached to a spherical body.
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broiler chickens from 90 ﬂocks belonging to 22 U.K. farms between
August and September 2002, managed to isolated Campylobacter from
63% of cecal samples (recovery was 102 to 107 colony forming units
(CFU)/g of cecal content). However, only 20% of the chickens harbored
Campylobacter phage present in a wide range of phage titers (recovery
was 102 to 107 plaque forming units (PFU)/g of cecal content). Interest-
ingly, El-Shibiny et al. (2005) found 51% of the 37 Campylobacter-
positive organic birds tested harbored Campylobacter phage (recovery
was 102 to 106 PFU/g of cecal content), indicating that birds with
more access to the environment had a higher colonization rate.
3.2. Characterization
Once isolated and puriﬁed, phages must undergo a variety of
genotypic and phenotypic tests necessary to identify them as suitable
candidates for use as biocontrol agents.
3.2.1. Lytic spectra
Determining the lytic activity of a phage is the most common char-
acterization, because it can help determine if the phage should be tested
further. Phages possessing broad lytic spectra are often highly desirable,
although phages capable of lysing bacterial strains that are less suscep-
tible to a wide variety of phages are also deemed beneﬁcial.
Lytic activity of a Campylobacter phage should be assessed with
a panel of reference Campylobacter strains that include C. jejuni
and C. coli, as well as wild-type isolates that reﬂect the environment
under study (Hansen et al., 2007). Ideally these bacterial isolates will
be well-characterized, either by phenotypic (e.g. serotyping, or phage
typing) or genotypic methods (e.g. Pulsed-Field Gel Electrophoresis
(PFGE), Multilocus Sequence Typing (MLST), or Restriction Fragment
Length Polymorphism (ﬂaA-RFLP)), prior to using in the panel. A
high-throughput and convenient method to test host susceptibility
against several phages simultaneously is the spot plate assay
where a small volume (i.e. 10 μL) of phage suspension of known
titer (i.e. c. 107 PFU/mL) is spotted onto the test bacterial lawn(s).
Susceptible bacteria will be lysed around the spot and a visible
clearing of the lawn will be seen, with sometimes only individual
plaques seen. However, results should be interpreted carefully and
if possible, a negative and positive control should be included in
the assay. As a positive control, a well-characterized phage that
produces a deﬁned type of lysis on the host strain is recommended.
This technique is similar to that used for phage typing of bacterial
strains (Frost et al., 1999). For a more quantitative approach, the
relative efﬁciency of plating (EOP) method could be undertaken
(Kutter, 2009). This method could be used on the phage(s) that
resulted in a clearing of the lawn using the spot plate assay. The phage
suspension would be serially diluted and all its dilutions spotted onto
a lawn of its propagation host as well as other susceptible bacterial
strains. The resulting titers would be compared against each other to
determine how virulent the phage is towards the different strains.
3.2.2. Morphological characteristics
A slightly more technical but relatively fast characterization
method commonly used is determining the structure of phages. Phages
can be examined using transmission electron microscopy (TEM)
(Ackermann, 2007) and more recently using atomic force microscopy
(Kuznetsov et al., 2011). It is advisable to have as high a titer of phage
suspension as possible, with a minimum titer of c. 108 PFU/mL neces-
sary to locate phage on the surface of a carbon-coated copper grid.
Phage suspensions may be concentrated using standard molecular
protocols such as ultraﬁltration membranes, polyethylene glycol (PEG)
precipitation, or cesium chloride equilibrium gradients (Sambrook and
Russell, 2001). Simple preparations for examining Campylobacter phage
under TEM are highlighted by Atterbury et al. (2003a), and Owens et
al. (2012). Some Campylobacter phages have been found to be membersof the Siphoviridae family, containing DNA inside an icosahedral
head, with a long non-contractile tail. However, the majority of de-
scribed Campylobacter phages belong to the Myoviridae family:
possessing an icosahedral head, long contractile tail and double
stranded DNA. Their average head diameters range from 80 to
140 nm, and tail lengths range from 95 to 120 nm. Interestingly, a few
TEM images of Campylobacter phages show them in a contracted-tail
state bound to spherical bodies (Loc Carrillo et al., 2007; Hwang et al.,
2009; Kropinski et al., 2011), speculated to be membrane vesicles
shed by C. jejuni as a defense mechanism against phage attack (Loeb,
1974; Kuehn and Kesty, 2005), as displayed by Fig. 1.
3.2.3. Protein proﬁling
Only two protein proﬁles of Campylobacter phage have been pub-
lished to-date (Timms et al., 2010; Hammerl et al., 2011). Timms et al.
(2010) used precast gels. They loaded their puriﬁed phage suspension
(c. 1010 PFU/mL) to gradient gels using the manufacturer's SDS sample
and gel running buffers, and followed the manufacturers' instructions.
The gels were run at 200 V for 35–50 min, and stained with colloidal
coomassie blue. Protein bands were excised and digested with trypsin,
before undergoing electrospray ionization followed by tandem mass
spectrometry (MS/MS). Both research groups used the Mascot Deamon
web server database to analyze their peptide sequences.
3.2.4. Genomic characterization
Pulsed-Field Gel Electrophoresis has been used extensively to de-
termine the genome size of most Campylobacter phages characterized
to-date (Sails et al., 1998; Atterbury et al., 2003a). It is recommended
to use at least a 109 PFU/mL suspension of phage for genome size
determination, and higher titers for restriction endonuclease analysis.
Once embedded in an agarose block, the protein-based structures of the
phage are degraded using proteinase K and a detergent (e.g., lauryl
sarkosyl). Proteinase K is then inactivated by washing the agarose
block at 55 °C and the washed block can be stored in TE buffer at 4 °C
for no more than 3 months. For restriction digest analysis, a number
of restriction enzymes have been used, although most have failed to
produce a restriction proﬁle (Sails et al., 1998; Hwang et al., 2009;
Owens et al., 2012). Table 1 highlights these restriction enzymes.
The inability for most of these restriction enzymes to digest phage
DNA has been due to methylation of phage DNA either via host
methyltransferases or phage-encoded methylases (Kropinski et al.,
Table 1
Restriction enzymes previously used to digest DNA from Campylobacter phages.
Unsuccessful digestions Variability in success
of digestion
Successful
digestions
AccI, AluI, AvaI, BamHI, ClaI, EcoRI,
EcoRV, HaeIII, HindIII, HpaII, KpnI,
PstI, PvuI, RsaI, SalI, SacI, ScaI, SmaI,
SphI, SspI, XbaI, and XhoI
DraI, MboI, Sau3AI,
and TaqI
HhaI
Table 3
Campylobacter phage sequences published to-date.
Phage Accession number Reference
CP220 EMBL: FN667788 (Timms et al., 2010)
CPt10 EMBL: FN667789 (Timms et al., 2010)
NCTC12673 GenBank: NC_015464.1 (Kropinski et al., 2011)
vB_CcoM-IBB_35 Unknown (Carvalho et al., 2012a)
CP81 GenBank: NC_019507.1 (Hammerl et al., 2012)
CP21 GenBank: NC_019507.1 (Hammerl et al., 2012)
CP30A GenBank: NC_018861.1 −
CPX GenBank: NC_016562.1 −
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dependent on the speculated fragment sizes, and PFGE apparatus man-
ufacturers such as Biorad provide helpful guidelines in their equipment
manuals. As size standards theMidRange I PFGMarker by New England
Biolabs or lambda concatemer have been successfully used.
Analysis at the genomic level was ﬁrst performed for the set of 16
Campylobacter typing phages (Sails et al., 1998). The majority of
Campylobacter phages possessing icosahedral heads and contractile
tails isolated so far may be grouped according to their genome sizes
as shown in Table 2 (Sails et al., 1998; Connerton et al., 2011). Coward
and colleagues identiﬁed subcategories within group III by studying
the development of spontaneous resistance between these phages
and certain Campylobacter phage-type strains, although phages with-
in groups I and II could not be subdivided. Interestingly, resistance to
phages in groups I and II have been associated with motility defects,
whereas resistance to phages in group III have been associated with
disruption of capsular polysaccharide (CPS) expression (Coward et
al., 2006).
Preparation of genomicDNA for sequencing requires highly puriﬁed,
high titer phage suspensions. A variety of protocols have been used to
isolated Campylobacter phage DNA, as has the technology to generate
DNA libraries, including use of the Roche's 454 Genome Sequencer
FLX system (Timms et al., 2010; Hammerl et al., 2011; Carvalho et
al.,2012b); proprietary technology by Fidelity Systems (Kropinski et
al., 2011); and shotgun sequencing (Timms et al., 2010). The extraction
methods used to obtain Campylobacter phage DNA plays an important
part in the information obtained. Proteins, which have been found to
be tightly bound to phage DNA, tend to be removed during the phenol
extraction procedure along with a signiﬁcant amount of (N80%) DNA.
Separation of DNA from proteins has also proved problematic with
the Qiagen genomic DNA puriﬁcation kit columns (Kropinski et al.,
2011). To add, phage genome sequencing has proved difﬁcult due to
their refractory properties to restriction enzyme digestion and an
inability to amplify DNA with regular Taq polymerase. It may be worth
noting that due to the small number of phage genomes sequenced so
far, and the limited bioinformatics data available to identify and annotate
genes, sequencing a phage does not guarantee to determine if the phage
carries ‘unknown’ genes coding for lysogeny, or ones that can promote a
bacterium's virulence or resistance properties (Carvalhoet al., 2012b). To
date, six Campylobacter phage sequences have been published, as
highlighted in Table 3.
3.2.5. Campylobacter prophages
The ability for bacteria to adapt and survive in various environments
is dependent on their genetic diversity. In addition to virulent phages,
temperate phages tend to be important for the genetic evolution andTable 2
Taxanomic grouping of Campylobacter phages based on genome size and phage resis-
tance development.
Group Average genome
size (Kb)
Phage resistance
associated with
Frequency
of isolation
I 320 Motility defect Rare
II 185 Motility defect Uncommon
III 135 Capsular polysaccharide
structure
Very frequently
isolatedvirulence of Campylobacters. The genetic diversity and instability of
C. jejuni strains have been shown to be due in part to the translocation
of aMu-like prophage sequence thatwasﬁrst discovered in the genome
of C. jejuni strain RM1221, which was also inducible by mitomycin C
(Fouts et al., 2005). Although initial attempts at inducing temperate
phage from Campylobacter were unsuccessful (Grajewski et al., 1985;
Salama et al., 1989), subsequent to the genome sequence of C. jejuni
RM 1221, prophages have been found to be widely distributed in 52
of 365 Campylobacter isolates tested for the presence of theMu-like pro-
phage (Clark, 2011). The presences of homologues sequences to this
prophage have been found to affect molecular typing results such as
PFGE patterns (Barton et al., 2007). Detailed analysis of Campylobacter
prophage sequences have revealed low GC content and repeats often
encountered in their host genome (Clark and Ng, 2008). Southern
blots and PCR-based techniques were employed to search for prophage
sequences found in C. jejuni strain RM1221. The majority of analyses
have been performed at the sequence level because common prophage
induction techniques (such as use of mitomycin C) do not work well
with Campylobacter species.
3.2.6. Interaction between Campylobacter phages and their hosts
Since phage genome sequencing is still in its infancy stage, it is
important to study the phage-host interactions through both in-vitro
and in-vivo studies in order to understand development of resistance.
Holst Sorensen et al. (2011) used the well-characterized Campylobacter
jejuni NCTC11168 strain to select for a phage-resistant mutant, in order
to determine the receptor site for Campylobacter phage F336. By using
periodate or proteinase K, they were able to elucidate that phage bind-
ing was due to a carbohydrate moiety rather than an outer membrane
protein on the surface of the phage-resistant mutant strain. With the
aid of high-resolutionmagic angle spinning nuclearmagnetic resonance
(HR-MAS NMR) analysis of intact bacterial cells, they found that the
difference between the susceptible wild type and resistant strain was a
modiﬁcation of the capsular polysaccharide's (CPS) hypervariable
O-methyl phosphoramidate structure. This structure has been found to
be highly abundant in C. jejuni strains although it is unknown how a de-
fect within this structure affects the virulence of the resistant-mutant
strain (Holst Sorensen et al., 2011). Scott et al. (2007a) used in-vivo
studies to investigate how Campylobacter phage CP34 predation upon
C. jejuni HPC5 populations in the avian gut, would affect the develop-
ment of phage-resistant mutants. Three phenotypes were discovered
from the strains isolated: resistance to phage, poor colonisers of the
chicken intestine, andproducers of a functionalMu-like phage, although
these were not seen with in-vitro kinetics studies. These phenotypes
resulted from intra-genomic inversions between Mu-like prophage se-
quences present in the parental strain. Interestingly, the reintroduction
of these phenotypes to chikens in the adsence of phage predation
resulted in bacterial genomic rearrangements that lead the population
to regain their competency at colonizing the chicken gut as well as re-
vert back to being sensitive to phage (Scott et al., 2007a).
The intriguing differences between results obtain from in-vitro and
in-vivo kinetic studies of phage-host interactions can be highlighted
by the work published by Loc Carrillo et al. (2005). A particular C. jejuni
strain (HPC5)was tested for its development of phage resistance to two
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in-vivo. In-vitro studies showed 8% and 11% of the colonies tested
became resistant to successive CP8 and CP34 phage infections, respec-
tively. In contrast, only 4% of colonies recovered from the CP34 phage
treated in-vivo studies gained resistance. Furthermore, isolates from
the in-vitro studies were not found to revert back to the sensitive phe-
notype after ﬁve consecutive subcultures. Kinetic differences between
these two phages and the target bacteria were also found to have
considerably different behaviors between their in-vitro and in-vivo
environments, as highlighted below (Loc Carrillo et al., 2005).
4. Use of phages to control Campylobacter in live birds and
food products
To-date, there have been a few studies looking at the feasibility to
use Campylobacter phages to control these pathogenic bacteria both
at the farm-level and on the processed carcass. Once a phage has
been characterized and deemed suitable for applications as an
antibacterial agent, there will be a number of in-vivo experiments
necessary to turn theory into practice.
4.1. Use in live birds
Table 4 highlights some in-vivo studies, which have investigated
the potential of phages to prevent and/or control Campylobacter in
the intestine of experimentally colonized birds. Wagenaar and col-
leagues were one of the ﬁrst to investigate the application of a single
Campylobacter phage type in live broilers as well as test the effect of a
two-phage treatment. They postulated that the addition of a second
phage might reduce the rate of phage-resistant mutants developing,
although the presence of such mutants was not tested for. The
authors state that the efﬁcacy of the combination of phages wasTable 4
In−vivo phage application to control Campylobacter in birds.
Type of phage
application
Campylobacter
phage(s) used
Treatment plan
Preventative Phage 71 (NCTC12671) 1. Single (1010 PFU) dose given to 7-day old chick
2. Chicks challenged with C. jejuni on day 10
3. Daily (1010 PFU) dose proceeds until day 16
4. Birds monitored up to day 42
Therapeutic Phage 71 (NCTC12671) 1. Chicks challenged with C. jejuni on day 10
2. Daily (1010 PFU) dose given from day 15 until d
3. Birds monitored up to day 42
Therapeutic Cocktail of two
phages: 71 and 69
1. Birds challenged with
C. jejuni on day 32
2. Daily (1010 PFU) dose given on days 39 to 42
3. Birds monitored up to day 58
Therapeutic Phage CP8 1. Birds challenged with C. jejuni on day 20
2. Three (105, 107, and 109 PFU) doses of phag
tested on day 25
3. Birds monitored up to day 30
Therapeutic Phage CP34 1. Birds challenged with C. jejuni on day 20
2. Three (105, 107, and 109 PFU) doses of phag
tested on day 25
3. Birds monitored up to day 30
Therapeutic Phage CP220 1. Birds challenged with Campylobacter on day 20
2. Three (105, 107, and 109 PFU) doses of phage
on day 25
3. Birds monitored up to day 30
Therapeutic Cocktail of 3 phages:
phiCcoIBB35
phiCcoIBB37
phiCcoIBB12
1. Chicks challenged with C. jejuni on day 1
2a. Single 106 PFU dose administered on day 7
oral gavage
2b. Phage feed given as 107 PFU in 45 g chick crumcomparable to their individual effects seen with in-vitro studies, to
determine that no antagonistic effect would occur (Wagenaar et al.,
2005).
Loc-Carrillo and colleagues studied two Campylobacter phages
(CP8 and CP34) in an in-vivomodel, based on in-vitro efﬁcacy studies.
Birds pre-colonized with two different wild-type Campylobacter strains
resulted in different outcomes after being treatedwith phage CP8. A sig-
niﬁcant drop in the population of C. jejuni GIIC8 colonizing the ceca,
after 1 day of treatment,was seen compared to the relatively unaffected
HPC5 population. However, when phage CP34 was used, the treatment
produced different results to phage CP8 against the C. jejuniHPC5 colo-
nizing the ceca, where the drop in bacterial loadwas not only lower but
alsomaintained for up to day 5 post treatment. Interestingly, the in-vivo
results were contrary to in-vitro results and the ability of phage CP8 in
killingC. jejuniHPC5 in-vitrowas not reproduced in the treated chickens
(Loc Carrillo et al., 2005),most likely due to the vastly different environ-
ments the bacterial population encountered between the chicken gut
and as homogenously grown planktonic cells in a ﬂask.
El-Shibiny et al. (2009) conducted similar in-vivo studies with a
wild-type C. coli OR12 strain that was used to colonize the birds and
treated with the same phage dosages. Only the highest dose of 109
PFU reduced the Campylobacter counts in the ceca by 1–2 Logs within
the ﬁrst 2 days (El-Shibiny et al., 2009).
Carvalho and colleagues tested the efﬁcacy of a phage cocktail on
chicks colonized by C. jejuni or C. coli. The phages chosen had different
complimentary lytic spectra. Phage treatment delivered through the
feed appeared to produce a slightly higher reduction of C. coli when
compared to administration by oral gavage. To minimize the number
of birds culled over the whole study, fecal and cloacal swab samples
were used to enumerate the number of Campylobacter excreted by
the chicks. Investigating the rate of phage resistance development
in Campylobacters passaged through the chick guts, they found 6% of
the isolates were resistant to phage despite not being exposed toOutcome Reference
s * Delayed on-set of colonization
* 1 Log lower cecal content
Wagenaar et al., 2005
ay 20
* 3 Log reduction in the ﬁrst 48 h
* By end of treatment cecal content matched
results to preventative group
Wagenaar et al., 2005
* 1.5 Log reduction seen during treatment period
* Steady increase then stabilization after 5 days
* 1 Log lower cecal content compared to untreated
group
Wagenaar et al., 2005
e
When birds colonized with HPC5:
* Phage persisted in intestine over the 5 days
* 1 Log reduction achieved on ﬁrst day
* No difference in cecal content compared to
untreated group
When birds colonized with GII8:
• Substantial reduction seen in ﬁrst 3 days
Loc Carrillo et al., 2005
e
* The 107 PFU dose produced largest reduction Loc Carrillo et al., 2005
tested
When birds colonized with C. jejuni:
* 107 PFU dose produced 2 Log reduction in ﬁrst
2 days
When birds colonized with C. coli:
* 109 PFU produced 1–2 Logs in ﬁrst 2 days
El-Shibiny et al. (2009)
by
bs
* 2 Log reduction seen up to 7 days post-treatment
with oral gavage
* 0.5 Log higher reduction seen with feed compared
to oral gavage
Carvalho et al. (2010b)
Box 1
Checklist for in-vivo studies.
□ Determine appropriate host(s) susceptible to phage(s), capable
of supporting an appropriate and reproducible in-vivo
colonization model.
□ Use 4–5 birds per time point to enumerate bacterial load.
□ Use birds that are appropriately aged to reflect the practical
applications.
□ Administer phage with 30% w/v CaCO3 to compensate for
acidic levels in chicken gut for oral gavages, or mix phage with
food.
□ If using multiple Campylobacter strains, use appropriate
methods for isolating and differentiating between isolates.
□ Test at least 10% of the colonies recovered from phage-treated
birds to determine rate of resistance.
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phage resistance after being exposed to phage treatment. After
passaging the resistant strains back through the chicken gut, they
found 86% of the colonies that were previously phage-resistant with-
out exposure to phage had reverted back to being sensitive, whereas
only 54% of the colonies that were phage-resistant after being
exposed to the phage treatment reverted back to their sensitive
phenotype (Carvalho et al., 2010b).
To examined the success of one C. jejuni genotype over another
under the inﬂuence of phage predation in-vivo, Scott and colleagues
used three different wild-type Campylobacter strains to colonize
chicken guts, singly (i.e., either with F2E1ϕR or F2E3ϕS or F2C10ϕS
strains) or in paired competition (i.e., F2E3ϕS and F2C10ϕS strains)
with and without Campylobacter phage CP30 to determine any colo-
nization beneﬁts or cost associated to a phage-resistant phenotype.
As expected, under a phage predation environment, colonization
levels of the phage-resistant strain did not differ to those found in
the absence of phage-treatment, whereas reduced levels in the popu-
lations of the phage sensitive strains were seen with the phage-
treatment. In-vivo studies of competitive colonization without a
phage predation pressure demonstrated that the phage-sensitive
strains could out-compete the phage-resistant strain. However, in the
presence of phage-treatment, the situation was reversed and the
phage-resistant strain was able to out-compete both phage-sensitive
strains. The authors concluded that phage predation can inﬂuence
Campylobacter populations that colonize chickens, selecting for particu-
lar variants between these populations. For the competitive colonization
studies, the group used neomycin in their CCDA media to differential
between F2E1ϕR and F2E3ϕS isolates, as well as colony blot and hybridi-
zation DIG-labeled probes speciﬁc for F2E1ϕR and F2E3/F2C10ϕS to
differentiate F2E1ϕR isolates from F2E3ϕS or F2C10ϕS isolates (Scott et
al., 2007b).
In a later study, Sørensen et al. (2012) found that the phase
variable O-methyl phosphoramidate (MeOPN) moiety of the C. jejuni
capsular polysaccharide (CPS) is the receptor involved in hindering
phage susceptibility of resistant mutants isolated after the co-infection
of chickens with both C. jejuni NCTC 11168 and phage F336. Most
interestingly, thesemutants also gained resistance to four other phages.
The investigators postulate that the constant exposure of Campylobacter
to phage predation in the chicken gut selects for different phage-host
co-evolution (Sørensen et al., 2012).
From the six in-vivo studies mentioned above, it may be worth
considering the criteria outlined in the checklist provided, when
setting-up future phage application studies (Box 1). Parameters that
have been investigated include a range of dosages, which have
surprisingly shown that the highest phage titer does not necessarily
result in the biggest reduction when compared to lower titers (Loc
Carrillo et al., 2005). In addition, results from in-vitro studies,
although insightful, cannot be used to predict how the application
of phages as antibacterial agents will work in-vivo. Multiple dosing
of phage-treatment can help suppress bacterial counts in feces during
treatment; however, cessation of treatment results in a rapid increase
in bacterial load, although still lower than the untreated controls
(Wagenaar et al., 2005). Timing of treatment is crucial, as most
phages studied so far have shown efﬁcacy at reducing bacterial
loads (up to 3 Logs) within the ﬁrst 2–3 days; however, regeneration
of the Campylobacter population steadily occurs after this time. Oral
gavage has been the main route for administering phages, although
foods such as chick crumbs have been used (Carvalho et al., 2010b),
which appears to be more practical if phage treatment is to be consider
feasible by the poultry industry. The delivery of phages through the
birds' drinking water has also been contemplated, although this has
not yet been tested. Phage cocktails have also been investigated
(Wagenaar et al., 2005; Carvalho et al., 2010b) in order to account for
the heterogeneous nature of Campylobacter, although no signiﬁcant im-
provement in their efﬁcacy was seen when compared to birds treatedwith individual phages. With that said, it is apparent that the use of
phage cocktails will target a broader range of bacteria, than treatments
containing only single phages.
4.2. Use in food products
The use of phages to control the level of Campylobacter contamina-
tion on the surface of chicken carcasses has also been investigated by
a number of research groups. Table 5 highlights the outcomes from
three studies. Two of the studies used chicken skin tainted with
know concentrations of susceptible Campylobacter cells (Goode et
al., 2003; Atterbury et al., 2003b), while another used raw and cooked
beef products with high and low bacterial loads treated with high and
low phage titers (Bigwood et al., 2008). In a later study involving
polynomial modeling, Bigwood and colleagues calculated that an
MOI of 105 would be required to kill at least 25% of a susceptible bac-
terial population on the surface of food within a 2 h period (Bigwood
et al., 2009).
5. Challenges and further research
It is clear that much work is still required to understand how best
to use phages to control pathogenic bacteria, although some progres-
sion has been made by the in-vivo and in-situ studies mentioned
above. In-vitro studies are important at helping to understand the
kinetics of phages against target hosts although they cannot be solely
relied upon since investigators have shown that there are discrepan-
cies between in-vitro and in-vivo results (Loc Carrillo et al., 2005).
On a laboratory scale, conventional methods such as liquid culture
or plate lysis methods can be employed for propagating Campylobacter
phages in small tomediumamounts (i.e., 10 mL to 1000 mL). However,
some of these phages are difﬁcult to propagate in liquid culture and
titers may vary considerably between batches. In addition, the plate
lysis method usually produces phage titers c. 108 PFU/mL, which
when considering that high phage titers are required for some studies,
optimization of propagation methods will need to be developed. For
larger phage stock volumes (i.e., N1 L), particularly important when
conducting large in-situ animal trials, the ability to scale-up phage
production will play an important part in considering the commercial
applications of phages. On an industrial scale, where large fermentation
vats are used to grow the propagation hosts, safety issues of growing
large volumes of a pathogen would be of great concern, and attenuated
strains capable of producing high phage titers would therefore be
needed.
To-date, all phage treatment studies against Campylobacter have
involved using ﬁltered phage lysates with no report of any adverse
effects seen from the recipients (i.e. chickens); however, the use of
highly puriﬁed phage preparations will need to be considered when
Table 5
In-situ phage application to control Campylobacter in food products.
Type of phage
application
Campylobacter
phage(s) used
Treatment
plan
Outcome Reference
Food decontamination Phage
NCTC 12673
1. Phage applied (106 PFU/cm2) to tainted
chicken skin and stored at 4 °C for 24 h
* 1 Log reduction seen with treated
compared to untreated group
Goode et al., 2003
Food decontamination Phage
NCTC 12674
1. Phage applied to chicken skin (from a
range between 104–7 PFU)
2. Skin stored at −20 °C or 4 °C for up
to 5 days
* 2 Log drop recovered from
frozen-thawed samples
* 1 Log drop seen from fresh samples
*No phage ampliﬁcation detected
*No phage-resistant mutants recovered
Atterbury et al., 2003b
Food decontamination Phage Cj6 1. Phage applied to raw and cooked
contaminated beef products
2. Skin stored at 5 °C or 24 °C for
up to 8 days
* 2 Log reduction seen with meats
containing high densities of host cells
* Similar results seen at both storage
temperatures
Bigwood et al., 2008
Food decontamination Phage:
NCTC12684, or CP81
1. Phage applied to raw chicken meat
at MOIs of 10 or 100
2. Meat stored at 4 °C for up to 7 days
* No reduction in bacterial load was
seen at 4 °C
Orquera et al., 2012
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bacterial toxins would have a detrimental effect on the consumer of
those phage treated products. One of the latest techniques used to
purify and concentrate phage preparations involves convective inter-
action media (CIM) monolithic columns, which have been previously
been used to purify and concentrate phages like phage T4 (Smrekar et
al., 2008). With further optimization, this technology may be used in
the future to purify large volumes of phage preparations in order to
remove endotoxins routinely produced by Gram-negative bacteria
such as Campylobacter.
Another hurdle in the application of phages to poultry, and in
particular live birds at the farm, is the development of phage-resistant
mutants (Loc Carrillo et al., 2005; Coward et al., 2006; Scott et al.,
2007a; Carvalho et al., 2010b). Further research is still needed to answer
which type of resistance is actually relevant for phage therapy and other
phage applications. This is particularly the case when considering the
use of phages in the primary production setting such as in chick hatch-
eries (Carvalho et al., 2012b). There is no current data available on the
distribution of phage resistant strains on a farm environment
following phage treatment of birds. It will also be interestingly to see
a phage therapy trial on naturally colonized broilers within a farm
environment.
The development of phage resistant mutants is thought to be less
unlikely when applying to commercial birds 1–2 days before going
through the processing plant. The prevalence of phage resistant
mutants may also be very limited when applying phages to carcasses
or food products stored at 4 °C, as studies have shown no bacterial
proliferation occurring (Atterbury et al., 2003b; Goode et al., 2003).
The next step would be to convince consumers that there are such
things as ‘good’ viruses!
6. Concluding remarks
The annual estimated cases of campylobacteriosis worldwide is
400–500 million, and the transmission of Campylobacter to humans
is attributed to the consumption of contaminated foods of animal
origins particularly poultry meat (Luangtongkum et al., 2009). Reduc-
ing the load of Campylobacter present in poultry at the farm and on
the carcass can save millions from the cost incurred by the loss of
productivity by the sufferer as well as from cases that lead to hospital
treatments. The use of phages to control the levels of Campylobacter
present in chickens has been explored since the start of themillennium,
and it is a particularly appealing method against antibiotic-resistant
strains, which have been steadily on the rise since the 1990s.
The use of phages to control pathogenic bacteria in the food indus-
try is an attractive concept since not only are they abundant in nature
(Hendrix et al., 1999) but they have also been found widely present
on foods (Whitman and Marshall, 1971; Atterbury et al., 2003a) aswell as isolated from the human intestine (Reyes et al., 2010). Recent-
ly, Goodridge and Bisha (2011) reviewed the potential use of phages
to control other bacterial pathogens present in animals used for food
production and in food products themselves, and concluded that
research studies have demonstrated the usefulness of phage applica-
tion in those settings (Goodridge and Bisha, 2011). It is clear that
phage research and looking at their applications to control bacteria
has gained considerable interest in the past decade particularly
since a number of commercial phage-based products are now avail-
able to apply on animal products and ready-to-eat foods (Monk et
al., 2010). Phage-based products against Campylobacter have not yet
reached the market place but a few companies have publically de-
clared interest in developing such products including Intralytix,
GangaGen and Micreos.
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